Patent(s) and the Corresponding Patented Drug(s) |
Top |
United States Patent and Trademark Office (USPTO) |
Patent ID |
US8865750 |
Title |
Small molecule inhibitors of RGS proteins |
Abstract |
The invention relates to compositions having RGS (regulator of G-protein Signaling) inhibiting activity, and methods of use thereof. In some embodiments, RGS-inhibiting compositions find use in research on or treatment of disease states (e.g., diabetes, epilepsy, neuropathic pain, depression and other diseases). |
Applicant(s) |
The Regents of The University of Michigan; The University of Bath |
Representative Drug(s) |
D01GFH |
Drug Info
|
IC50 > 100000nM |
Click to Show More |
[1] |
2
|
D0E9JL
|
Drug Info
|
IC50 > 100000nM
|
[1] |
Patent ID |
US8865750 |
Title |
Small molecule inhibitors of RGS proteins |
Abstract |
The invention relates to compositions having RGS (regulator of G-protein Signaling) inhibiting activity, and methods of use thereof. In some embodiments, RGS-inhibiting compositions find use in research on or treatment of disease states (e.g., diabetes, epilepsy, neuropathic pain, depression and other diseases). |
Applicant(s) |
The Regents of The University of Michigan; The University of Bath |
Representative Drug(s) |
D01GFH |
Drug Info
|
IC50 > 100000nM |
Click to Show More |
[1] |
2
|
D0E9JL
|
Drug Info
|
IC50 > 100000nM
|
[1] |
Patent ID |
US8865750 |
Title |
Small molecule inhibitors of RGS proteins |
Abstract |
The invention relates to compositions having RGS (regulator of G-protein Signaling) inhibiting activity, and methods of use thereof. In some embodiments, RGS-inhibiting compositions find use in research on or treatment of disease states (e.g., diabetes, epilepsy, neuropathic pain, depression and other diseases). |
Applicant(s) |
The Regents of The University of Michigan; The University of Bath |
Representative Drug(s) |
D01GFH |
Drug Info
|
IC50 > 100000nM |
Click to Show More |
[1] |
2
|
D0E9JL
|
Drug Info
|
IC50 > 100000nM
|
[1] |